Introduction: Euphorbia antiquorum is a fleshy shrub belonging to the family Euphorbiaceae. It is widely distributed in the hotter parts of India. It is used as a substitute for the Ayurvedic drug 'Snuhee' whose accepted botanical source is Euphorbia neriifolia Linn. The leaf, stem, latex and root of Snuhee are used in treatment of diseases and conditions like, diabetes, coryza, and oedema. Objective: The present study is aimed to investigate the renal protective effect of E. antiquorum alcoholic extracts of the stem on alloxan (150mg/kg) induced d iabetic Wistar rats. Methods: All animals were treated for 21 days and sacrificed on the last day. Unwanted placebo effect in case of the control group was blocked by executing appropriate vehicle treatment and same animal handling pattern. Extract and standard drug doses given orally wer e suspended in 0.9% normal saline. Blood samples were drawn from retro orbital sinus using Diethyl-ether anesthesia at weekly intervals for 3 weeks. Blood samples were labeled in such a way that analysis team was kept blind about groups and nature of the study design. Body weight measurement and blood sampling were done on 1 st , 7 th , 14 th and 21 st day of the study. Conclusion: 21 days daily treatment with a test drug of ethanolic extract of stems of Euphorbia antiquorum significantly reduced the elevated Blood glucose level, Urinary Albumin, urine creatinine, serum creatinine in alloxan induced diabetic rats.
INTRODUCTION
India as a country is blessed with a rich heritage of traditional medical systems along with rich biodiversity to accomplish the herbal needs, as therapeutic benefits administered by these traditional and alternative medical systems. The Indian systems of medicine are Ayurveda, Siddha and Unani, which use herbs and minerals in the formulations. India which use 15 agro-climatic zones, 4700 plant species of which 15000 are reported to have medicinal properties varying degrees. [1] The various parts of Euphorbia antiquorum have been associated with a number of pharmacological activities which are Cytotoxic activity, Hepatoprotective and antioxidant activity, Insecticidal activity of Euphorbia antiquorum L., Anti-hyperglycaemic and Insilco Aldose reductase inhibitory activity (Amutha, et al., 2012) , Cancer , Anti-inflammatory and anti-arthritic activities. [2] [3] [4] [5] [6] [7] Diabetic nephropathy appears in patients with both type 1 and type 2 diabetes after five to 10 years of active diabetes, and is heralded by the onset of abnormal amounts of albumin in the urine, termed micro-albuminuria, defined as a urinary albumin excretion rate of 20-200μg/min in a timed specimen, 30-300mg/24 hours, or an albumin to creatinine ratio of 30-300g albumin/mg creatinine on a morning spot urine test. The spot urine/creatinine ratio has been shown to have high sensitivity and specificity for urinary albumin excretion compared with a timed measurement of urinary albumin. [8] Diabetes is the most common cause of kidney failure, accounting for nearly 44 percent of new cases. Even when diabetes is controlled, the disease can lead to chronic kidney disease (CKD) and kidney failure. Kidney failure is the final stage of chronic kidney disease. Nearly 24 million people in the United States have diabetes and nearly 180 000 people are living with kidney failure as a result of diabetes. The prevalence of nephropathy in India was less (8.9% in Vellore, 5.5% in Chennai) when compared with the prevalence of 22.3% in Asian Indians in the UK. In chronic renal failure patients the prevalence of diabetic nephropathy was 30.3% followed by chronic interstitial nephritis (23%) and chronic glomerulonephritis (17.7%). [9] Alloxan is most widely used in experimental diabetic research. Alloxan produces selective necrosis of the beta cells of pancreas. The alloxan is administered by various routes like intravenous, intraperitoneal and subcutaneous. Alloxan is used for induction of diabetes in experimental animals such as mice, rats, rabbits and dogs. The routes and dose of alloxan required may vary depending upon the animal species. [10] [11] 
MATERIALS AND METHODS

Plant material
Fresh stems of E. antiquorum were collected from the vicinity of Varansi district in Uttar Pradesh, India during the month of January, 2018 and air dried. The plant material was identified and authenticated by Prof. N. K. Dubey, Taxonomist, FNASc and FNAAS, Center of Advanced Study in Botany, Institute of Science, BHU, Varanasi, India. The voucher herbarium specimen (Euphorbia.2018/4) has been deposited in the Department of Botany.
Animals
All the animals used for the study were healthy and active in their cage. Studies were carried out using male Wistar rats weighing 170-200 g. The animals were bred, reared and housed in the animal house of BNU University with CPCSEA no. (03/BNCP/IAEC/2018) . The rats were group housed in polyacrylic cages (38×23×10cm) with not more than six animals per cage and maintained under standard laboratory conditions (temperature 25 ± 2 0 C) and relative humidity 50% (±10%), with a dark and light cycle of 12 ± 1 h. They were allowed free access to standard dry pellet diet (Amrut, India) and water ad libitum and kept in quarantine for a week to acclimatize with animal house facility(CPCSEA guideline,7th January, 2010). The animals were maintained in accordance with the guidelines specified by the Committee for the Purpose of Control and Supervision of Experiments on Animals (CPCSEA), Ministry of Environment and Forests (Animal Welfare Division), Govt of India, New Delhi.
Preparation of extracts
Coarsely powdered (200 g) stem was extracted with 95% (V/ V) alcohol in a soxhlet apparatus. The extract obtained was filtered and subjected to concentration at a temperature below 50oC to obtain a dark brown semi solid mass [yield 17.3% (W/W)]. The extract was suspended in distilled water and used for further studies [12] [13] 
Experimental design .
Group-I (Normal or vehicle control): Group I animals were non diabetic and served as normal control and received 0.9% normal saline. Six healthy animals with moderate hyperglycemia, i.e. serum glucose between the normal ranges were randomly selected.
Group II (Diabetic control): Rats served as diabetic control, which were injected a single dose of 150mg/kg b.w. of Alloxan monohydrate ( ip) with 0.9% normal saline.
Group III: Diabetic rats were treated with ethanolic plant extract by gavages (200 mg/kg/day b.w., p.o) in 0.9% normal saline once daily for 21 days.
Group IV: Diabetic rats were treated with ethanolic plant extract by gavages (400 mg/kg b.w., p.o.) in 0.9% normal saline once daily for 21 days.
Group V: Which served as positive control, diabetic rats were treated with metformin by gavages (200 mg/kg b.w., p.o.) in 0.9% normal saline once daily for 21 days. [14] [15] All animals were treated for 21 days and sacrificed on the last day. Unwanted placebo effect in case of each control group was blocked by executing appropriate vehicle treatment and same animal handling pattern. Extract and standard drug doses given orally were suspended in 0.9% normal saline. Blood samples were drawn from retro orbital sinus using diethyl-ether anesthesia after 3 weeks. Blood samples were labeled in such a way that analysis team was kept blind about groups and nature of study design. Body weight measurement and blood sampling were done on 21st day of the study. Animals (rats) were sacrificed, dissected and organs were cleaned and collected and kept in a suitable container. [16] 3. RESULTS 
DISCUSSION
Effect of different doses of ethanolic extract of stems of Euphorbia antiquorum (EAE) and metformin on blood glucose level of alloxan-induced diabetic rat:
After administration of 7 th day of EAE at doses of 400 mg/kg b.w. (Group IV) significantly (p<0.05) reduced the blood glucose of alloxan-induced diabetic rats ( 
Effect of different doses of ethanolic extract of stems of Euphorbia antiquorum (EAE) and metformin on urine creatinine level of alloxan-induced diabetic rat:
EAE at doses of 200 & 400 mg/kg b.w. (Group IV) significantly reduced the urine creatinine level of alloxaninduced diabetic rats (Table 3.3 & Figure 3.4) , similar to what was seen in the standard (metformin) group (Group V). Group IV) significantly reduced urinary albumin level to 1.87±0.79mg/dl (***p < 0.001 vs. diabetic control group). The urinary albumin level of EAE at doses of 400 mg/kg b.w. (Group IV) demonstrated a notable significant decline to 1.87±0.79mg/dl (***p < 0.001 vs. diabetic control group) but which is not even better than metformin (200 mg/Kg b.w) treated group (Group V) that reduced urinary albumin level to 1.62±0.24mg/dl (***p < 0.001 vs. diabetic control group) at day of 21.
CONCLUSION
According to the standard working protocol, 21 days daily treatment with a test drug of ethanolic extract of stems of Euphorbia antiquorum significantly reduced the elevated Urinary Albumin, urine creatinine, serum creatinine in alloxan induced diabetic rats. Euphorbia antiquorum with oral hypoglycemic agents may be a valuable adjutant therapy to achieve and/or maintain glycemic control and possibly reduce or delay the onset of diabetic complications. Thus, these results offer scientific validation of ethanolic extract of stems of Euphorbia antiquorum in the management of diabetes mellitus in time-honored medicine system of India. Further studies will be carried out in future to identify the active antidiabetic principles of this plant that are responsible. It can be thereby suggested further for the investigations on humans to study the harmonizing effect of the amalgamation of ethanolic extract of stems of Euphorbia antiquorum and metformin on other body tissues.
